| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
289,870,000 |
| Market
Cap: |
51.80(B) |
| Last
Volume: |
2,692,202 |
Avg
Vol: |
1,552,953 |
| 52
Week Range: |
$165.15 - $249.08 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : 11.4 |
| Insider 6 Months : 11.4 |
| Insider 3/6 Months : 23.2 |
|
| Guru Rank Number : 77 |
| Guru Rank Value : 11.5 |
| Guru Occurances : 4 |
|
|
|
|
|
| |
|
Company Profile Becton, Dickinson and Company is a medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. Co.'s business segments are: BD Medical, which produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings; BD Life Sciences, which provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers; and BD Interventional, which provides vascular, urology, oncology and surgical products.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
5,250 |
5,250 |
6,750 |
6,750 |
| Total Buy Value |
$1,005,743 |
$1,005,743 |
$1,356,173 |
$1,356,173 |
| Total People Bought |
1 |
1 |
2 |
2 |
| Total Buy Transactions |
1 |
1 |
2 |
2 |
| Total Shares Sold |
1,952 |
4,303 |
21,012 |
33,304 |
| Total Sell Value |
$370,281 |
$783,534 |
$4,529,980 |
$7,432,744 |
| Total People Sold |
2 |
4 |
8 |
9 |
| Total Sell Transactions |
5 |
7 |
20 |
27 |
| End Date |
2025-08-03 |
2025-05-02 |
2024-11-01 |
2023-11-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Feld Michael |
EVP & President, Life Sciences |
• – – |
2025-10-27 |
4 |
S |
$186.01 |
$10,603 |
D/D |
(57) |
8,245 |
|
4% |
|
| Feld Michael |
EVP & President, Life Sciences |
• – – |
2025-09-26 |
4 |
S |
$181.03 |
$10,500 |
D/D |
(58) |
8,302 |
|
3% |
|
| Fraser-Liggett Claire |
Director |
– • – |
2025-09-10 |
4 |
S |
$187.50 |
$171,938 |
D/D |
(917) |
22,226 |
|
5% |
|
| Delorefice Christopher |
EVP & Chief Financial Officer |
• – – |
2025-09-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(278) |
21,221 |
|
- |
|
| Byrd Richard |
EVP & President Interventional |
• – – |
2025-09-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(216) |
6,736 |
|
- |
|
| Feld Michael |
EVP & President, Life Sciences |
• – – |
2025-08-22 |
4 |
S |
$197.99 |
$11,285 |
D/D |
(57) |
8,360 |
|
10% |
|
| Feld Michael |
EVP & President, Life Sciences |
• – – |
2025-08-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(773) |
8,417 |
|
- |
|
| Hayes Gregory |
Director |
– • – |
2025-08-11 |
4 |
B |
$191.57 |
$1,005,743 |
D/D |
5,250 |
6,046 |
2.39 |
-7% |
|
| Fraser-Liggett Claire |
Director |
– • – |
2025-08-08 |
4 |
S |
$192.30 |
$165,955 |
D/D |
(863) |
23,143 |
|
7% |
|
| Garrison Michael David |
EVP & President, Medical |
• – – |
2025-07-18 |
4 |
S |
$180.29 |
$213,645 |
D/D |
(1,185) |
4,887 |
|
-0% |
|
| Garrison Michael David |
EVP & President, Medical |
• – – |
2025-07-18 |
4 |
D |
$180.29 |
$933,001 |
D/D |
(5,175) |
6,072 |
|
- |
|
| Garrison Michael David |
EVP & President, Medical |
• – – |
2025-07-18 |
4 |
OE |
$147.68 |
$939,245 |
D/D |
6,360 |
11,247 |
|
- |
|
| Muhsin Bilal |
EVP & President Connected Care |
• – – |
2025-07-02 |
4 |
A |
$0.00 |
$0 |
D/D |
12,221 |
12,221 |
|
- |
|
| Shan David |
EVP and Chief ISC Officer |
• – – |
2025-06-02 |
4 |
S |
$171.19 |
$199,608 |
D/D |
(1,166) |
4,575 |
|
-12% |
|
| Garrison Michael David |
EVP & President, Medical |
• – – |
2025-04-09 |
4 |
S |
$197.28 |
$94,497 |
D/D |
(479) |
4,887 |
|
5% |
|
| Neal Shana Carol |
EVP and Chief People Officer |
• – – |
2025-04-04 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,886) |
13,528 |
|
- |
|
| Hayes Gregory |
Director |
– • – |
2025-03-26 |
4 |
A |
$0.00 |
$0 |
D/D |
796 |
796 |
|
- |
|
| Byrd Richard |
EVP & President Interventional |
• – – |
2025-03-18 |
4 |
S |
$230.00 |
$105,570 |
D/D |
(459) |
6,952 |
|
21% |
|
| Byrd Richard |
EVP & President Interventional |
• – – |
2025-03-12 |
4 |
S |
$224.91 |
$436,325 |
D/D |
(1,940) |
7,411 |
|
19% |
|
| Garrison Michael David |
EVP & President Medical |
• – – |
2025-03-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(178) |
5,366 |
|
- |
|
| Scott Bertram L |
Director |
– • – |
2025-02-12 |
4 |
S |
$227.99 |
$159,593 |
D/D |
(700) |
36,033 |
|
24% |
|
| Henderson Jeffrey William |
Director |
– • – |
2025-02-10 |
4 |
B |
$233.62 |
$350,430 |
D/D |
1,500 |
8,015 |
2.39 |
-27% |
|
| Spikner Pamela L. |
SVPController & Chief Acct Off |
• – – |
2025-02-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
682 |
|
-25% |
|
| Brown William M |
Director |
– • – |
2025-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
930 |
3,486 |
|
- |
|
| Fraser-Liggett Claire |
Director |
– • – |
2025-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
930 |
24,006 |
|
- |
|
823 Records found
|
|
Page 1 of 33 |
|
|
0.67 (0.37%) 
